penicillamine has been researched along with Erythroblastosis Fetalis in 2 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lakatos, L | 2 |
| Kövér, B | 2 |
| Oroszlán, G | 1 |
| Vekerdy, Z | 2 |
| Dvoracsek, E | 1 |
2 other studies available for penicillamine and Erythroblastosis Fetalis
| Article | Year |
|---|---|
D-penicillamine therapy in ABO hemolytic disease of the newborn infant.
Topics: ABO Blood-Group System; Age Factors; Bilirubin; Erythroblastosis, Fetal; Exchange Transfusion, Whole | 1976 |
[Penicillamine D therapy of hemolytic disease of newborn and neonatal hyperbilirubinemia].
Topics: Erythroblastosis, Fetal; Female; Humans; Hyperbilirubinemia; Infant, Newborn; Jaundice, Neonatal; Pe | 1975 |